22
Participants
Start Date
March 31, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Glufosfamide
5000 mg/m2 of glufosfamide on Day 1 of each three-week cycle for up to 6 cycles.
St. Vincent's Comprehensive Cancer Center, New York
H. Lee Moffitt Cancer Center, Tampa
Washington University School of Medicine, Division of Oncology, St Louis
Premiere Oncology of Arizona, Scottsdale
Arizona Cancer Center, Tucson
University of New Mexico Cancer Research and Treatment Center, Albuquerque
Stanford Cancer Center, Stanford
Lead Sponsor
Collaborators (1)
Threshold Pharmaceuticals
INDUSTRY
Eleison Pharmaceuticals LLC.
INDUSTRY